Saudi Pharmaceutical Journal : SPJ, 24(4), 413-428
The Dangers of Dosing Errors The FDA has reported an increase in adverse events related to dosing errors with compounded semaglutide
It supports immune function, cardiovascular health, and skin health, and may also have anti-inflammatory properties
Amylin Agonists: A Novel Approach in the Treatment of Diabetes
488 patients (15.3%) had CV risk factors without established CV disease or CKD
GLP-1 medications have demonstrated effects beyond weight loss that are directly relevant to Medicare's covered disease populations: reductions in cardiovascular events in patients with established heart disease (Wegovy's FDA approval for cardiovascular risk reduction), improvements in blood sugar control, reductions in sleep apnea severity, and improvements in kidney function